February 28, 2015 3:10 AM ET


Company Overview of Avid Radiopharmaceuticals, Inc.

Executive Profile

Daniel M. Skovronsky M.D., Ph.D.

Founder, Chief Executive Officer, President and Director, Avid Radiopharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships


Dr. Daniel M. Skovronsky, also known as Dan, M.D., Ph.D., is the Founder, Chief Executive Officer, and President at Avid Radiopharmaceuticals Inc. Dr. Skovronsky founded the firm in 2004. Prior to establishing the firm, he served as Scientific Director of High Throughput Screening and Drug Discovery at the Center for Neurodegenerative Disease Research at the University of Pennsylvania. Dr. Skovronsky served as Vice President of Radiopharmaceutical Development at Theracor ...

Corporate Headquarters

3711 Market Street
Philadelphia, Pennsylvania 19104

United States

Phone: 215-298-0700
Fax: 413-826-0416

Board Members Memberships

Founder, Chief Executive Officer, President and Director


Yale University
The University of Pennsylvania
The University of Pennsylvania

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Avid Radiopharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.